The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.

A••••••• I••

Borrower
group grade Aoff every schedule since Sep 30, 2025sponsor unattributed
Also written as: Biotechnology & Life Sciences; Pharmaceuticals
No date on record · this record

Nothing material in the last 200 days. No dated change on record yet.

Mark path, consensus per quarter end
Q3 2024: 99¢Q4 2024: 100¢Q1 2025: 100¢Q2 2025: 100¢99¢ · 100¢ · 100¢ · 100¢Q3 2024 to Q2 2025
Principal held
unknown
sum of BDC pieces, a lower bound
Fair value
Not disclosed
n/a on cost, debt pieces
Unfunded
$0
commitments not yet drawn
BDC lenders
4
1 on the latest quarter
Facilities
5
0 equity pieces beside them
Next maturity
unstated
no dated debt inside 24 months
On the tape since
Sep 30, 2022
latest Sep 30, 2025
Events
6
dated, non-routine
Lender marks
each lender's own fair value over cost at Sep 30, 2025, folded to one row per lender
LenderExposureCurrent markQoQ change
O•••••• S•••••••• L•••••• C•••no principal filedno cost filedno comparable mark
Every BDC piece · 1 position across 1 lenderlargest principal first, with instrument and rate
BDCInstrumentPrincipalFair valueRate
O•••••• S•••••••• L•••••• C•••unstated lien unstatedNot disclosedNot disclosed
Capital structure as the BDCs see it
latest quarter end Sep 30, 2025
FacilityHeldOn costPricingMaturityBDCs
first lien term loan first lien
exited Sep 30, 2024
at least $20.0M98cS+600 bpJan 16, 20261
first lien revolver first lien
exited Sep 30, 2024
at least $2.5M99cS+600 bpJan 16, 20261
delayed draw term loan lien unstated
exited Jul 31, 2024
at least $2.0Mn/aS+600 bpJan 16, 20261
first lien delayed draw term loan first lien
exited Dec 31, 2022
at least $0n/aS+550 bpunstated1
other lien unstated
exited Sep 30, 2025
unknownn/aunstated1
Through time
the borrower's pieces summed across BDCs, every quarter end
Quarter endBDCsPrincipal heldFair valueOn costPIK pieces
Sep 30, 20251$0$0n/a0
Jun 30, 20252$48.5M$47.7M100c0
Mar 31, 20252$47.9M$47.0M100c0
Dec 31, 20242$96.1M$94.2M100c0
All 14 quarters
Quarter endBDCsPrincipal heldFair valueOn costPIK pieces
Sep 30, 20242$29.3M$28.9M99c0
Jul 31, 20241$8.0M$5.9M100c0
Jun 30, 20242$29.5M$29.4M100c0
Mar 31, 20242$29.5M$29.3M100c0
Dec 31, 20232$29.1M$28.8M99c0
Sep 30, 20232$29.2M$28.9M99c0
Jun 30, 20232$29.2M$28.9M99c0
Mar 31, 20232$28.9M$28.6M100c0
Dec 31, 20222$23.8M$23.6M101c0
Sep 30, 20221$33.0M$32.9M102c0
What changed
Full timeline · 12 events
Every change including routine ones
Identity
Group key
ACCUPACderivedthe codename stem after legal suffixes and deal words
Spellings
1 across 4 BDCsderived

Position history

19 field-level changes across filed schedules, latest first
  • Position exitedO•••••• S•••••••• L•••••• C•••
    2025-12-31
  • Principal decreasedF• S•••••••• L•••••• F••• · $96.1M to $47.9M
    2025-03-31
  • New positionF• S•••••••• L•••••• F••• · at $96.1M
    2024-12-31
  • Position exitedN••••• C•••••••• P•••••• C•••••• I••••• F••• · from $6.8M
    2024-12-31
  • Position exitedO•••••• S•••••••• L•••••• C••• · from $20.0M
    2024-12-31
  • Position exitedO•••••• S•••••••• L•••••• C••• · from $2.5M
    2024-12-31
  • Principal increasedO•••••• S•••••••• L•••••• C••• · $2.0M to $2.5M
    2024-03-31
  • Spread widenedO•••••• S•••••••• L•••••• C••• · 5.50% to 6.00%
    2023-09-30
  • Spread widenedO•••••• S•••••••• L•••••• C••• · 5.50% to 6.00%
    2023-09-30
  • Spread widenedN••••• C•••••••• P•••••• C•••••• I••••• F••• · 5.50% to 6.00%
    2023-09-30

Each line is one position compared between two consecutive BDC schedules of investments: principal, fair value mark, spread, PIK and maturity, as filed with the SEC.